It is a pharma private limited company based in Vadodara, Gujarat, India, established in 2013.
2013 | Vadodara, Gujarat, India | ActiveDominant Pharma Private Limited, a active private limited company, was established on 09 January 2013 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239GJ2013PTC073315. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Hudka Ripal Vrajlal (Director), Umesh Karshanbhai Mendapara (Director). Past directors included Avinasbhai Hareshkumar Pandya, Umesh Karshanbhai Mendapara, Maheshbhai Manjibhai Vadher. It holds ₹0.84 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 210, C-1, Lotus Aura-2, Opp Lileriya Party Plot, Sama Savali Main Road,, Vadodara, Gujarat, 390008.
U24239GJ2013PTC073315
073315
09 January 2013
₹0.10 M
₹0.10 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Dominant Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hudka Ripal Vrajlal | Director | 09 Jan 2013 | Current |
| Umesh Karshanbhai Mendapara | Director | 10 Feb 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Nov 2016 | Past |
| Pramod Abcsdd | Additional Director | 31 Mar 2016 | Past |
| Pramod Abcsdd | Director | 01 Apr 2016 | Past |
| Pramod Abcsdd | Director | 10 Nov 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dominant Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 16% increase. The company also saw a slight decrease in profitability, with a 3.81% decrease in profit. The company's net worth Soared by an impressive increase of 23.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Dominant Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹840,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2020 | State Bank Of India | ₹0.84 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dominant Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dominant Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dominant Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dominant Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Dominant Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The activity A charge with State Bank Of India amounted to Rs. 0.84 M with Charge ID 100352391 was registered on 27 Jul 2020. was completed.
Umesh Karshanbhai Mendapara was appointed as a Director was appointed as a Director on 10 Feb 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.
Progress on Hudka Ripal Vrajlal was appointed as a Director was appointed as a Director on 09 Jan 2013 & has been associated with this company since 12 years 10 months . was documented.
Progress on Dominant Pharma Private Limited was registered on 09 Jan 2013 with Roc Ahmedabad & aged 12 years 10 months as per MCA records. was documented.
The CIN of Dominant Pharma Private Limited is U24239GJ2013PTC073315.
Dominant Pharma Private Limited is headquartered at 210, C-1, Lotus Aura-2, Opp Lileriya Party Plot, Sama Savali Main Road,, Vadodara, Gujarat, 390008.
Dominant Pharma Private Limited was incorporated on 09 January 2013.
The current directors of Dominant Pharma Private Limited are
The primary industry of Dominant Pharma Private Limited is Trade.
Dominant Pharma Private Limited is unlisted.
The authorized capital of Dominant Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Dominant Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX